UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
-
-
-
-
-
-
Esperion Therapeutics (ESPR) Prices 3.1M Share Common Offering at $49/Sh
-
-
-
-
-
-
-
UPDATE: UBS Upgrades Esperion Therapeutics (ESPR) to Buy
-
-
-
-
-
-
-
Esperion Therapeutics (ESPR) PT Lowered to $69 at UBS; 'Buy' Maintained
-
-
-
-
-
-
-
Notable Analyst Rating Changes 6/25: (MRO) (LLY) (ODP) Upgraded; (ALE) (CHK) (NFLX) Downgraded
-
-
-
-
-
-
-
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock
-
-
-
-
-
160,874 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

